The Bombay High Court has ruled that an Reserve Bank of India official's unauthorized absence from work is grave misconduct. The court dism...

India is the AI Partner Country at VivaTech 2026 in Paris. The nation will display its advancements in sovereign AI capabilities and self-r...

Addressing an 'Intellectuals Meet' organised in Hyderabad by Telangana BJP, he said that through Operation Sindoor, the government had show...

Harsh Goenka, chairman of RPG Enterprises with a reported net worth of $2.7 billion, shared a reflective post urging people not to delay li...

After 12 years at the helm, Prime Minister Narendra Modi reflects on a transformative journey filled with key reforms that have altered Ind...

India's younger consumers are embracing cold coffee as an everyday drink. Brands like Nestle, HUL, and Tata Starbucks are expanding their o...

Invesco Mutual Fund's Hiten Jain offers a contrarian view, identifying the tech rout as a significant buying opportunity and dismissing bro...

Globalisation is changing. It now balances efficiency with resilience and security. This shift benefits India, a nation with strong tech ta...

PPFAS CIO Rajiv Thakkar said successful investing depends more on patience than frequent trading. He advised avoiding unnecessary selling, ...

ICICI Prudential AMC CIO S. Naren described the current market as a “boring phase,” marked by a tug-of-war between FIIs and domestic mutual...

Malayalam actor Indrans is winning praise for his performance in Suriya's Karuppu. His understated role as a father searching for his daugh...

Market veteran Ambareesh Baliga sees Indian equities well-positioned if geopolitical tensions ease and macro conditions remain supportive. ...

Wockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...

Markets often climb despite worries. In 2020, markets rose before economic recovery became clear. Now, in 2026, a similar pattern emerges a...

Several small and midcap stocks have achieved multibagger status in 2026, offering substantial returns. Companies in sectors like fiber opt...

Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...

As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...